Qube Research & Technologies Ltd

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$679,171

+$611,602 QoQ

Shares Held

194,049

+1008.5% QoQ

Ownership

0.315%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#29

of 135 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. VYGR ranks #122 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,171	194,049	+1008.5%	Shares	Sole	2026-08-14
2026-03-31	$67,569	17,505	+136.1%	Shares	Sole	2026-05-15
2024-03-31	$69,015	7,413	-78.3%	Shares	Sole	2024-05-14
2023-12-31	$288,335	34,163	-65.2%	Shares	Sole	2024-02-13
2023-09-30	$760,143	98,083	+19.1%	Shares	Sole	2023-11-13
2023-03-31	$634,733	82,326	+176.1%	Shares	Sole	2023-05-15
2022-12-31	$181,914	29,822	+18.5%	Shares	Sole	2023-02-14
2022-09-30	$148,964	25,163	+35.1%	Shares	Sole	2022-11-14
2022-06-30	$110,038	18,619	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.